Home » Healthcare » Chronic Pain Market

Chronic Pain Market By Product (Drugs, Devices); By Indication (Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Others); By Application (Musculoskeletal, Neuropathy, Oncology, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $4699

Published: | Report ID: 47556 | Report Format : PDF
REPORT ATTRIBUTE DETAILS
Historical Period 2019-2022
Base Year 2023
Forecast Period 2024-2032
Chronic Pain Market Size 2023 USD 78,923.16 million 
Chronic Pain Market, CAGR 5.37%
Chronic Pain Market Size 2032 USD 84,550.38 million

Market Overview:

The global chronic pain market is projected to grow from USD 78,923.16 million in 2023 to USD 84,550.38 million by 2032, at a compound annual growth rate (CAGR) of 5.37%.

This growth trajectory represents a significant market opportunity for stakeholders in the healthcare sector. The market is undergoing a paradigm shift towards personalized and integrated pain management approaches. This shift is fuelled by a growing understanding of the multifaceted nature of chronic pain and the need for tailored treatment plans. The integration of digital health solutions, such as telemedicine platforms and wearable devices, is playing a pivotal role in improving patient access to care and enhancing treatment outcomes. Regulatory initiatives aimed at promoting patient-centric care and ensuring the safety and efficacy of pain management therapies are shaping the market’s regulatory environment.

Looking ahead, the Chronic Pain Market is expected to sustain its growth trajectory, driven by ongoing research and development activities, strategic collaborations, and investments in novel therapeutic modalities. Key players in the market are focusing on innovation and differentiation to capture a larger market share and address unmet patient needs. Evolving healthcare policies and reimbursement frameworks are anticipated to further bolster market growth, ensuring continued access to essential pain management interventions for patients worldwide. The market presents significant opportunities for stakeholders across the healthcare ecosystem to drive meaningful advancements in pain management and improve patient quality of life.

Furthermore, the market is experiencing a paradigm shift towards personalized and integrated pain management approaches. This shift is driven by a growing understanding of the multifaceted nature of chronic pain and the need for tailored treatment plans. The integration of digital health solutions, such as telemedicine platforms and wearable devices, is also playing a pivotal role in improving patient access to care and enhancing treatment outcomes. Moreover, regulatory initiatives aimed at promoting patient-centric care and ensuring the safety and efficacy of pain management therapies are shaping the market’s regulatory environment.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Market Drivers:

Technological Advancements:

The chronic pain market is propelled by continuous technological advancements, including the development of innovative medical devices and procedures. Advancements such as neuromodulation techniques, implantable drug delivery systems, and minimally invasive surgical procedures have significantly improved the management of chronic pain conditions. These technologies offer patients more effective pain relief options while minimizing risks and improving overall quality of life. For instance, neuromodulation techniques have been shown to reduce pain levels of patients. Similarly, implantable drug delivery systems have resulted in a improvement in pain control and reduction in medication-related side effects.

Increasing Aging Population:

The growing aging population worldwide is a key driver of the chronic pain market. As individuals age, they are more prone to developing chronic pain conditions due to age-related changes in the musculoskeletal system, nervous system, and other physiological factors. This demographic trend has led to a higher prevalence of chronic pain disorders, driving demand for pain management solutions, pharmaceuticals, and rehabilitation services. For instance, it is estimated that 50% of the elderly population suffers from some form of chronic pain. As a result, the demand for pain management solutions has increased by 20% in the last five years.

Rising Incidence of Chronic Diseases:

The rising incidence of chronic diseases such as arthritis, cancer, diabetes, and neurological disorders contributes significantly to the demand for chronic pain management. These conditions often result in persistent pain that requires long-term management and treatment. Consequently, pharmaceutical companies are investing in research and development to introduce novel pain medications, targeting specific pathways and mechanisms to provide effective relief for patients with chronic pain.

Shift Towards Multimodal Treatment Approaches:

There is a notable shift towards multimodal treatment approaches in chronic pain management. Healthcare providers are increasingly adopting comprehensive strategies that combine pharmacological interventions with non-pharmacological therapies such as physical therapy, cognitive-behavioral therapy, acupuncture, and lifestyle modifications. This holistic approach aims to address the multifaceted nature of chronic pain, improve patient outcomes, and reduce reliance on opioid medications, aligning with global efforts to combat the opioid epidemic.

Market Trends:

Growing Demand for Non-Opioid Pain Management Solutions:

The chronic pain market is witnessing a significant shift towards non-opioid pain management solutions due to the rising awareness of opioid-related risks and the need for safer alternatives. Patients and healthcare providers are increasingly opting for non-addictive options such as nonsteroidal anti-inflammatory drugs (NSAIDs), physical therapy, acupuncture, and medical cannabis to manage chronic pain conditions effectively. For instance, studies have shown that physical therapy can reduce pain levels and improve mobility of patients. This trend is driven by the growing emphasis on patient safety, improved treatment outcomes, and regulatory initiatives aimed at reducing opioid misuse and addiction. Market players are investing heavily in research and development (R&D) to innovate and commercialize advanced non-opioid pain therapies, driving the expansion of this segment within the chronic pain market.

Integration of Digital Health Technologies:

Another notable trend in the chronic pain market is the integration of digital health technologies to enhance patient care, monitoring, and treatment outcomes. Digital solutions such as telemedicine platforms, mobile health applications, wearable devices, and remote patient monitoring systems are being leveraged to provide personalized and remote chronic pain management services. These technologies facilitate real-time data collection, analysis, and communication between patients and healthcare providers, enabling timely interventions, adherence monitoring, and personalized treatment plans. For instance, a recent survey showed that 80% of patients found telemedicine consultations as effective as in-person visits. Moreover, the COVID-19 pandemic has accelerated the adoption of digital health solutions, driving their integration into standard chronic pain management practices. As a result, market players are collaborating with technology firms to develop innovative digital tools and platforms tailored to address the unique needs of chronic pain patients, thereby shaping the future of pain management strategies and healthcare delivery models.

Market Challenges Analysis:

Regulatory Hurdles and Compliance Issues:

One significant challenge in the chronic pain market revolves around navigating complex regulatory landscapes and ensuring compliance with stringent guidelines. Regulatory bodies often impose rigorous requirements for the approval and marketing of chronic pain treatments, including opioids and non-opioid medications. Meeting these standards demands substantial financial investments, extensive clinical trials, and meticulous documentation. Moreover, evolving regulations and frequent policy changes add layers of uncertainty, making it difficult for companies to predict the long-term viability of their products. This dynamic regulatory environment necessitates continuous monitoring, strategic adaptations, and robust compliance frameworks to mitigate risks and maintain market presence.

Competitive Landscape and Innovation Barriers:

Another critical challenge in the chronic pain market stems from intense competition and barriers to innovation. With numerous players vying for market share, differentiation becomes crucial yet challenging. Established pharmaceutical companies, alongside emerging biotech firms and medical device manufacturers, continually introduce new therapies, technologies, and delivery methods, intensifying competition and driving the need for innovation. However, developing innovative solutions for chronic pain involves substantial research and development costs, clinical validation, and regulatory approval hurdles. Additionally, intellectual property protection and market exclusivity timelines further complicate the landscape, making it arduous for companies to sustain competitive advantages and launch breakthrough products. Overcoming these innovation barriers requires strategic collaborations, robust intellectual property strategies, and a deep understanding of market dynamics to drive sustainable growth and address unmet patient needs.

Market Segmentation Analysis:

By Product

Firstly, in terms of products, the chronic pain market can be segmented into pharmaceuticals, medical devices, and alternative therapies. Pharmaceuticals encompass a wide range of pain-relief medications, including opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and anticonvulsants. Medical devices include implantable devices like spinal cord stimulators and infusion pumps designed to manage chronic pain. Alternative therapies such as acupuncture, physical therapy, and herbal remedies also play a significant role in this segment.

By Indication

Secondly, market segmentation based on indications focuses on the specific types of chronic pain that these products and therapies target. Common indications include neuropathic pain, musculoskeletal pain, cancer pain, and chronic migraine. Understanding the prevalence and characteristics of each indication helps companies tailor their products and services to meet the diverse needs of patients suffering from different types of chronic pain.

By Application

Thirdly, the application segment of market segmentation looks at how these products and therapies are applied or administered. For example, pharmaceuticals may be administered orally, intravenously, or through transdermal patches. Medical devices require surgical implantation or external application, while alternative therapies involve techniques such as acupuncture needles or physical exercises. Analyzing these application methods helps in optimizing treatment outcomes and patient experiences.

By Distribution Channel

Lastly, distribution channels play a crucial role in delivering chronic pain products and services to end-users. These channels include hospitals and clinics, retail pharmacies, online pharmacies, and direct-to-consumer sales. Each channel has its advantages and challenges, and companies must strategize their distribution networks to ensure widespread availability and accessibility of their offerings.

Segmentation:

By Product:

  • Drugs
  • Devices

By Indication:

  • Neuropathic Pain
  • Arthritis Pain
  • Chronic Back Pain
  • Cancer Pain
  • Migraine
  • Fibromyalgia
  • Others

By Application:

  • Musculoskeletal
  • Neuropathy
  • Oncology
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Geography:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

Regional Analysis:

The chronic pain market is witnessing significant growth across various regions, driven by an aging population, increasing prevalence of chronic diseases, and advancements in pain management therapies.

North America dominates the global chronic pain market, accounting for approximately 46.5% of the market share in 2024. The United States and Canada are the primary contributors to this regional growth, supported by well-established healthcare infrastructure, high healthcare expenditure, and the presence of major market players. The region’s robust pharmaceutical landscape and ongoing research and development efforts in chronic pain therapeutics further solidify its leadership position. The aging population and the rising incidence of chronic conditions, such as arthritis, neuropathy, and cancer, are key factors driving the demand for effective pain management solutions in North America.

Europe follows closely, capturing around 30% of the market share. Countries like Germany, the UK, France, Italy, and Spain are at the forefront of this growth, driven by favorable regulatory frameworks and well-established healthcare systems that ensure accessibility to pain management therapies. The region’s emphasis on preventive care and early intervention strategies, coupled with increasing awareness about the importance of effective pain management, contributes to the market’s expansion. The growing geriatric population and the rising prevalence of chronic diseases, such as osteoarthritis and neuropathic pain, further fuel the demand for chronic pain treatments in Europe.

Asia-Pacific is emerging as the fastest-growing region, projected to capture approximately 20% of the global chronic pain market share by 2030. Countries like China, Japan, India, and Australia are leading this growth, driven by rapid urbanization, economic development, and increasing healthcare awareness. The region’s large population, coupled with the rising incidence of chronic diseases and the growing acceptance of pain management therapies, presents significant opportunities for market players. Factors such as improving healthcare infrastructure, increasing disposable incomes, and government initiatives aimed at enhancing access to healthcare services are also contributing to the market’s expansion in Asia-Pacific.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key Player Analysis:

  • Pfizer Inc.
  • Johnson & Johnson
  • Novartis International AG
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly and Company
  • AstraZeneca PLC
  • Purdue Pharma L.P.
  • AbbVie Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.

Competitive Analysis:

In the chronic pain market, a competitive analysis reveals a landscape characterized by robust innovation and strategic partnerships. Key players such as Pfizer, Eli Lilly, and Johnson & Johnson dominate with a diverse portfolio of analgesic drugs and medical devices targeting specific pain types. Emerging entrants like Teva Pharmaceuticals and Endo International are gaining traction through novel formulations and expanded market reach. Furthermore, the market witnesses continuous R&D investments focusing on personalized pain management solutions and non-opioid alternatives, driven by regulatory pressures and shifting patient preferences. Collaborations between pharmaceutical giants and tech companies for digital health platforms are also reshaping the competitive dynamics, emphasizing a holistic approach to chronic pain care and enhancing patient outcomes.

Recent Developments:

  • Forever Cheer, a pharmaceutical firm holding more than 10 global patents, selected Hong Kong in December 2023 as the springboard for the worldwide debut of their groundbreaking pain management medications. Through this launch in Hong Kong, the company intends to broaden its global presence and effect meaningful change within the healthcare sector.
  • In August 2023, MOBE and Override, both pioneers in digital health, formed a partnership to introduce a joint savings initiative focused on managing chronic pain. This program strives to deliver a tailored method to pain management while lowering healthcare expenses, employing data analytics alongside behavioral health coaching.

Market Concentration & Characteristics:

The chronic pain market exhibits notable market concentration characterized by a limited number of dominant players wielding significant market share. These key players often possess extensive research and development capabilities, allowing them to introduce innovative pain management solutions and maintain a competitive edge. Additionally, market characteristics include a growing emphasis on personalized treatment approaches tailored to individual patient needs, driven by advancements in precision medicine and digital health technologies. Furthermore, regulatory frameworks play a pivotal role in shaping market dynamics, with stringent compliance requirements influencing product development, marketing strategies, and market access. Overall, the chronic pain market is marked by intense competition, technological advancements, and regulatory complexities, creating both challenges and opportunities for industry stakeholders.

Report Coverage:

The research report offers an in-depth analysis based on product, indication, application, and distribution channel. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook:

  • The chronic pain market is expected to experience substantial growth, driven by the increasing prevalence of chronic diseases and the aging population, leading to a heightened demand for effective pain management solutions.
  • Advances in technology, including telehealth services and innovative pain management devices, are enhancing treatment options and accessibility for patients suffering from chronic pain.
  • The rising awareness of non-opioid alternatives is reshaping treatment paradigms, as healthcare providers and patients seek safer pain management strategies amid concerns over opioid addiction.
  • Regulatory bodies are increasingly supportive of new therapies and technologies, facilitating faster approvals and market entry for innovative pain management solutions.
  • The growing focus on personalized medicine is expected to drive the development of tailored pain management therapies that address individual patient needs and improve treatment outcomes.
  • Increased investment in research and development by pharmaceutical companies and medical device manufacturers is anticipated to yield new and effective pain relief options.
  • The integration of artificial intelligence and data analytics in pain management is likely to enhance diagnostic accuracy and treatment efficacy, paving the way for more effective interventions.
  • Emerging markets in Asia-Pacific are projected to witness rapid growth due to improving healthcare infrastructure and rising awareness of chronic pain management.
  • Collaborations and partnerships among industry stakeholders, including healthcare providers and technology firms, are expected to foster innovation and expand market reach.
  • Overall, the chronic pain market is poised for significant transformation, with evolving treatment modalities and a strong emphasis on patient-centred care driving future growth.

CHAPTER NO. 1 : INTRODUCTION 30

1.1.1. Report Description 30

Purpose of the Report 30

USP & Key Offerings 30

1.1.2. Key Benefits for Stakeholders 30

1.1.3. Target Audience 31

1.1.4. Report Scope 31

1.1.5. Regional Scope 32

CHAPTER NO. 2 : EXECUTIVE SUMMARY 33

2.1. CHRONIC PAIN  Market Snapshot 33

2.1.1. Global CHRONIC PAIN Market, 2018 – 2032 (USD Million) 34

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 35

3.1. Russia-Ukraine and Israel-Palestine War Impacts 35

CHAPTER NO. 4 : CHRONIC PAIN  MARKET – INDUSTRY ANALYSIS 36

4.1. Introduction 36

4.2. Market Drivers 37

4.2.1. Increasing incidences of arthritis and other painful disease 37

4.2.2. Newer technique for pain management 38

4.3. Market Restraints 39

4.3.1. Treatment costs are high 39

4.4. Market Opportunities 40

4.4.1. Market Opportunity Analysis 40

4.5. Porter’s Five Forces Analysis 41

4.6. Value Chain Analysis 42

4.7. Buying Criteria 43

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 44

5.1. Import Analysis by Region 44

5.1.1. Global CHRONIC PAIN  Market Import Volume/Revenue, By Region, 2018 – 2023 44

5.2. Export Analysis by Region 45

5.2.1. Global CHRONIC PAIN  Market Export Volume/Revenue, By Region, 2018 – 2023 45

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 46

6.1. Demand Analysis by Region 46

6.1.1. Global CHRONIC PAIN  Market Demand Volume/Revenue, By Region, 2018 – 2023 46

6.2. Supply Analysis by Region 47

6.2.1. Global CHRONIC PAIN  Market Supply Volume/Revenue, By Region, 2018 – 2023 47

CHAPTER NO. 7 : PRODUCTION ANALYSIS 48

7.1. Production Analysis by Region 48

7.1.1. Global CHRONIC PAIN  Market Production Volume/Revenue, By Region, 2018 – 2023 48

CHAPTER NO. 8 : PRICE ANALYSIS 49

8.1. Price Analysis by Region 49

8.1.1. Global CHRONIC PAIN  Market Price, By Region, 2018 – 2023 49

8.1.2. Global By Indication Market Price, By Region, 2018 – 2023 49

8.2. Price Analysis by By Indication 50

8.2.1. Global CHRONIC PAIN  Market Price, By By Indication, 2018 – 2023 50

8.2.2. Global By Indication Market Price, By By Indication, 2018 – 2023 50

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 51

9.1. Key Raw Materials and Suppliers 51

9.2. Key Raw Materials Price Trend 51

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 52

10.1. Manufacturing Cost Analysis 52

10.2. Manufacturing Process 52

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 53

11.1. Company Market Share Analysis – 2023 53

11.1.1. Global CHRONIC PAIN  Market: Company Market Share, by Volume, 2023 53

11.1.2. Global CHRONIC PAIN  Market: Company Market Share, by Revenue, 2023 54

11.1.3. Global CHRONIC PAIN  Market: Top 6 Company Market Share, by Revenue, 2023 54

11.1.4. Global CHRONIC PAIN  Market: Top 3 Company Market Share, by Revenue, 2023 55

11.2. Global CHRONIC PAIN Market Company Volume Market Share, 2023 56

11.3. Global CHRONIC PAIN  Market Company Revenue Market Share, 2023 57

11.4. Company Assessment Metrics, 2023 58

11.4.1. Stars 58

11.4.2. Emerging Leaders 58

11.4.3. Pervasive Players 58

11.4.4. Participants 58

11.5. Start-ups /SMEs Assessment Metrics, 2023 58

11.5.1. Progressive Companies 58

11.5.2. Responsive Companies 58

11.5.3. Dynamic Companies 58

11.5.4. Starting Blocks 58

11.6. Strategic Developments 59

11.6.1. Acquisitions & Mergers 59

New Product Launch 59

Regional Expansion 59

11.7. Key Players Product Matrix 60

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 61

12.1. PESTEL 61

12.1.1. Political Factors 61

12.1.2. Economic Factors 61

12.1.3. Social Factors 61

12.1.4. Technological Factors 61

12.1.5. Environmental Factors 61

12.1.6. Legal Factors 61

12.2. Adjacent Market Analysis 61

CHAPTER NO. 13 : CHRONIC PAIN  MARKET – BY BY INDICATION SEGMENT ANALYSIS 62

13.1. CHRONIC PAIN  Market Overview, by By Indication Segment 62

13.1.1. CHRONIC PAIN  Market Revenue Share, By By Indication, 2023 & 2032 63

13.1.2. CHRONIC PAIN  Market Attractiveness Analysis, By By Indication 64

13.1.3. Incremental Revenue Growth Opportunity, by By Indication, 2024 – 2032 64

13.1.4. CHRONIC PAIN  Market Revenue, By By Indication, 2018, 2023, 2027 & 2032 65

13.2. Neuropathic Pain 66

13.2.1. Global Neuropathic Pain CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 67

13.2.2. Global Neuropathic Pain CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 67

13.3. Arthritis pain 68

13.3.1. Global Arthritis pain CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 69

13.3.2. Global Arthritis pain CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 69

13.4. Chronic Back pain 70

13.4.1. Global Chronic Back pain  CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 71

13.4.2. Global Chronic Back pain  CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 71

13.5. Cancer Pain 72

13.5.1. Global Cancer Pain CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 73

13.5.2. Global Cancer Pain CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 73

13.6. Migraine 74

13.6.1. Global Migraine CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 75

13.6.2. Global Migraine CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 75

CHAPTER NO. 14 : CHRONIC PAIN  MARKET – BY DRUG CLASS SEGMENT ANALYSIS 76

14.1. CHRONIC PAIN  Market Overview, by Drug Class Segment 76

14.1.1. CHRONIC PAIN  Market Revenue Share, By Drug Class, 2023 & 2032 77

14.1.2. CHRONIC PAIN  Market Attractiveness Analysis, By Drug Class 78

14.1.3. Incremental Revenue Growth Opportunity, by Drug Class, 2024 – 2032 78

14.1.4. CHRONIC PAIN  Market Revenue, By Drug Class, 2018, 2023, 2027 & 2032 79

14.2. Opiods 80

14.2.1. Global Opiods CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 81

14.2.2. Global Opiods CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 81

14.3. Non steroidal Anti inflamatory drugs 82

14.3.1. Global Non steroidal Anti inflamatory drugs  CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 83

14.3.2. Global Non steroidal Anti inflamatory drugs  CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 83

14.4. Anticonvulsants 84

14.4.1. Global Anticonvulsants CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 85

14.4.2. Global Anticonvulsants CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 85

14.5. Antidepressants 86

14.5.1. Global Antidepressants CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 87

14.5.2. Global Antidepressants CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 87

14.6. Drug Class 5 88

14.6.1. Global Drug Class 5 CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 89

14.6.2. Global Drug Class 5 CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 89

CHAPTER NO. 15 : CHRONIC PAIN  MARKET – BY APPLICATION  SEGMENT ANALYSIS 90

15.1. CHRONIC PAIN  Market Overview, by Application  Segment 90

15.1.1. CHRONIC PAIN  Market Revenue Share, By Application , 2023 & 2032 91

15.1.2. CHRONIC PAIN  Market Attractiveness Analysis, By Application 92

15.1.3. Incremental Revenue Growth Opportunity, by Application , 2024 – 2032 92

15.1.4. CHRONIC PAIN  Market Revenue, By Application , 2018, 2023, 2027 & 2032 93

15.2. Musculoskeletal 94

15.2.1. Global Musculoskeletal CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 95

15.2.2. Global Musculoskeletal CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 95

15.3. Neuropathy 96

15.3.1. Global Neuropathy CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 97

15.3.2. Global Neuropathy CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 97

15.4. Oncology 98

15.4.1. Global Oncology CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 99

15.4.2. Global Oncology CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 99

15.5. Others 100

15.5.1. Global Others CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 101

15.5.2. Global Others CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 101

15.6. Application  5 102

15.6.1. Global Application  5 CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 103

15.6.2. Global Application  5 CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 103

CHAPTER NO. 16 : CHRONIC PAIN  MARKET – BY TECHNOLOGY SEGMENT ANALYSIS 104

16.1. CHRONIC PAIN  Market Overview, by Technology Segment 104

16.1.1. CHRONIC PAIN  Market Revenue Share, By Technology, 2023 & 2032 105

16.1.2. CHRONIC PAIN  Market Attractiveness Analysis, By Technology 106

16.1.3. Incremental Revenue Growth Opportunity, by Technology, 2024 – 2032 106

16.1.4. CHRONIC PAIN  Market Revenue, By Technology, 2018, 2023, 2027 & 2032 107

16.2. Technology 1 108

16.2.1. Global Technology 1 CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 109

16.2.2. Global Technology 1 CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 109

16.3. Technology 2 110

16.3.1. Global Technology 2 CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 111

16.3.2. Global Technology 2 CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 111

16.4. Technology 3 112

16.4.1. Global Technology 3 CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 113

16.4.2. Global Technology 3 CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 113

16.5. Technology 4 114

16.5.1. Global Technology 4 CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 115

16.5.2. Global Technology 4 CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 115

16.6. Technology 5 116

16.6.1. Global Technology 5 CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 117

16.6.2. Global Technology 5 CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 117

CHAPTER NO. 17 : CHRONIC PAIN  MARKET – BY DISTRIBUTION CHANNEL SEGMENT ANALYSIS 118

17.1. CHRONIC PAIN  Market Overview, by Distribution Channel Segment 118

17.1.1. CHRONIC PAIN  Market Revenue Share, By Distribution Channel, 2023 & 2032 119

17.1.2. CHRONIC PAIN  Market Attractiveness Analysis, By Distribution Channel 120

17.1.3. Incremental Revenue Growth Opportunity, by Distribution Channel, 2024 – 2032 120

17.1.4. CHRONIC PAIN  Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 121

17.2. Hospital Pharmacies 122

17.2.1. Global Hospital Pharmacies CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 123

17.2.2. Global Hospital Pharmacies CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 123

17.3. Retail Pharmacies 124

17.3.1. Global Retail Pharmacies CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 125

17.3.2. Global Retail Pharmacies CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 125

17.4. Others 126

17.4.1. Global Others CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 127

17.4.2. Global Others CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 127

17.5. 128

17.5.1. Global   CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 129

17.5.2. Global   CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 129

17.6. Distribution Channel 5 130

17.6.1. Global Distribution Channel 5 CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 131

17.6.2. Global Distribution Channel 5 CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 131

CHAPTER NO. 18 : CHRONIC PAIN  MARKET – REGIONAL ANALYSIS 132

18.1. CHRONIC PAIN  Market Overview, by Regional Segments 132

18.2. Region 133

18.2.1. Global CHRONIC PAIN  Market Revenue Share, By Region, 2023 & 2032 133

18.2.2. CHRONIC PAIN  Market Attractiveness Analysis, By Region 134

18.2.3. Incremental Revenue Growth Opportunity, by Region, 2024 – 2032 134

18.2.4. CHRONIC PAIN  Market Revenue, By Region, 2018, 2023, 2027 & 2032 135

18.2.5. Global CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 136

18.2.6. Global CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 136

18.3. By Indication 137

18.3.1. Global CHRONIC PAIN  Market Revenue, By By Indication, 2018 – 2023 (USD Million) 137

18.4. Global CHRONIC PAIN  Market Revenue, By By Indication, 2024 – 2032 (USD Million) 137

18.5. Drug Class 138

18.5.1. Global CHRONIC PAIN  Market Revenue, By Drug Class, 2018 – 2023 (USD Million) 138

18.5.2. Global CHRONIC PAIN  Market Revenue, By Drug Class, 2024 – 2032 (USD Million) 138

18.6. Application 139

18.6.1. Global CHRONIC PAIN  Market Revenue, By Application , 2018 – 2023 (USD Million) 139

18.6.2. Global CHRONIC PAIN  Market Revenue, By Application , 2024 – 2032 (USD Million) 139

18.7. Technology 140

18.7.1. Global CHRONIC PAIN  Market Revenue, By Technology, 2018 – 2023 (USD Million) 140

18.7.2. Global CHRONIC PAIN  Market Revenue, By Technology, 2024 – 2032 (USD Million) 140

18.8. Distribution Channel 141

18.8.1. Global CHRONIC PAIN  Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 141

18.8.2. Global CHRONIC PAIN  Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 141

CHAPTER NO. 19 : CHRONIC PAIN  MARKET – NORTH AMERICA 142

19.1. North America 142

19.1.1. Key Highlights 142

19.1.2. North America CHRONIC PAIN  Market Revenue, By Country, 2018 – 2023 (USD Million) 143

19.1.3. North America CHRONIC PAIN  Market Revenue, By By Indication, 2018 – 2023 (USD Million) 144

19.1.4. North America CHRONIC PAIN  Market Revenue, By Drug Class, 2018 – 2023 (USD Million) 145

19.1.5. North America CHRONIC PAIN  Market Revenue, By Application , 2018 – 2023 (USD Million) 146

19.1.6. North America CHRONIC PAIN  Market Revenue, By Technology, 2018 – 2023 (USD Million) 147

19.1.7. North America CHRONIC PAIN  Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 148

19.2. U.S. 149

19.3. Canada 149

19.4. Mexico 149

CHAPTER NO. 20 : CHRONIC PAIN  MARKET – EUROPE 150

20.1. Europe 150

20.1.1. Key Highlights 150

20.1.2. Europe CHRONIC PAIN  Market Revenue, By Country, 2018 – 2023 (USD Million) 151

20.1.3. Europe CHRONIC PAIN  Market Revenue, By By Indication, 2018 – 2023 (USD Million) 152

20.1.4. Europe CHRONIC PAIN  Market Revenue, By Drug Class, 2018 – 2023 (USD Million) 153

20.1.5. Europe CHRONIC PAIN  Market Revenue, By Application , 2018 – 2023 (USD Million) 154

20.1.6. Europe CHRONIC PAIN  Market Revenue, By Technology, 2018 – 2023 (USD Million) 155

20.1.7. Europe CHRONIC PAIN  Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 156

20.2. UK 157

20.3. France 157

20.4. Germany 157

20.5. Italy 157

20.6. Spain 157

20.7. Russia 157

20.8. Belgium 157

20.9. Netherland 157

20.10. Austria 157

20.11. Sweden 157

20.12. Poland 157

20.13. Denmark 157

20.14. Switzerland 157

20.15. Rest of Europe 157

CHAPTER NO. 21 : CHRONIC PAIN  MARKET – ASIA PACIFIC 158

21.1. Asia Pacific 158

21.1.1. Key Highlights 158

21.1.2. Asia Pacific CHRONIC PAIN  Market Revenue, By Country, 2018 – 2023 (USD Million) 159

21.1.3. Asia Pacific CHRONIC PAIN  Market Revenue, By By Indication, 2018 – 2023 (USD Million) 160

21.1.4. Asia Pacific CHRONIC PAIN  Market Revenue, By Drug Class, 2018 – 2023 (USD Million) 161

21.1.5. Asia Pacific CHRONIC PAIN  Market Revenue, By Application , 2018 – 2023 (USD Million) 162

21.1.6. Asia Pacific CHRONIC PAIN  Market Revenue, By Technology, 2018 – 2023 (USD Million) 163

21.1.7. Asia Pacific CHRONIC PAIN  Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 164

21.2. China 165

21.3. Japan 165

21.4. South Korea 165

21.5. India 165

21.6. Australia 165

21.7. Thailand 165

21.8. Indonesia 165

21.9. Vietnam 165

21.10. Malaysia 165

21.11. Philippines 165

21.12. Taiwan 165

21.13. Rest of Asia Pacific 165

CHAPTER NO. 22 : CHRONIC PAIN  MARKET – LATIN AMERICA 166

22.1. Latin America 166

22.1.1. Key Highlights 166

22.1.2. Latin America CHRONIC PAIN  Market Revenue, By Country, 2018 – 2023 (USD Million) 167

22.1.3. Latin America CHRONIC PAIN  Market Revenue, By By Indication, 2018 – 2023 (USD Million) 168

22.1.4. Latin America CHRONIC PAIN  Market Revenue, By Drug Class, 2018 – 2023 (USD Million) 169

22.1.5. Latin America CHRONIC PAIN  Market Revenue, By Application , 2018 – 2023 (USD Million) 170

22.1.6. Latin America CHRONIC PAIN  Market Revenue, By Technology, 2018 – 2023 (USD Million) 171

22.1.7. Latin America CHRONIC PAIN  Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 172

22.2. Brazil 173

22.3. Argentina 173

22.4. Peru 173

22.5. Chile 173

22.6. Colombia 173

22.7. Rest of Latin America 173

CHAPTER NO. 23 : CHRONIC PAIN  MARKET – MIDDLE EAST 174

23.1. Middle East 174

23.1.1. Key Highlights 174

23.1.2. Middle East CHRONIC PAIN Market Revenue, By Country, 2018 – 2023 (USD Million) 175

23.1.3. Middle East CHRONIC PAIN  Market Revenue, By By Indication, 2018 – 2023 (USD Million) 176

23.1.4. Middle East CHRONIC PAIN  Market Revenue, By Drug Class, 2018 – 2023 (USD Million) 177

23.1.5. Middle East CHRONIC PAIN  Market Revenue, By Application , 2018 – 2023 (USD Million) 178

23.1.6. Middle East CHRONIC PAIN  Market Revenue, By Technology, 2018 – 2023 (USD Million) 179

23.1.7. Middle East CHRONIC PAIN  Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 180

23.2. UAE 181

23.3. KSA 181

23.4. Israel 181

23.5. Turkey 181

23.6. Iran 181

23.7. Rest of Middle East 181

CHAPTER NO. 24 : CHRONIC PAIN  MARKET – AFRICA 182

24.1. Africa 182

24.1.1. Key Highlights 182

24.1.2. Africa CHRONIC PAIN  Market Revenue, By Country, 2018 – 2023 (USD Million) 183

24.1.3. Africa CHRONIC PAIN  Market Revenue, By By Indication, 2018 – 2023 (USD Million) 184

24.1.4. Africa CHRONIC PAIN  Market Revenue, By Drug Class, 2018 – 2023 (USD Million) 185

24.1.5. Africa CHRONIC PAIN  Market Revenue, By Application , 2018 – 2023 (USD Million) 186

24.1.6. Africa CHRONIC PAIN  Market Revenue, By Technology, 2018 – 2023 (USD Million) 187

24.1.7. Africa CHRONIC PAIN  Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 188

24.2. Egypt 189

24.3. Nigeria 189

24.4. Algeria 189

24.5. Morocco 189

24.6. Rest of Africa 189

CHAPTER NO. 25 : COMPANY PROFILES 190

25.1. Abbott Laboratories 190

25.1.1. Company Overview 190

25.1.2. Product Portfolio 190

25.1.3. Swot Analysis 190

25.1.4. Business Strategy 191

25.1.5. Financial Overview 191

25.2. Pfizer Inc. 192

25.3. Eli Lilly & Company 192

25.4. Cara Therapeutics 192

25.5. Chattem (Sanofi) 192

25.6. Endo International plc 192

25.7. Merck & Co. Inc. 192

25.8. F. Hoffmann-La Roche AG. 192

25.9. Company 9 192

25.10. Company 10 192

25.11. Company 11 192

25.12. Company 12 192

25.13. Company 13 192

25.14. Company 14 192

List of Figures

FIG NO. 1. Global CHRONIC PAIN  Market Revenue, 2018 – 2032 (USD Million) 30

FIG NO. 2. Porter’s Five Forces Analysis for Global CHRONIC PAIN  Market 37

FIG NO. 3. Value Chain Analysis for Global CHRONIC PAIN  Market 38

FIG NO. 4. Global CHRONIC PAIN  Market Import Volume/Revenue, By Region, 2018 – 2023 40

FIG NO. 5. Global CHRONIC PAIN  Market Export Volume/Revenue, By Region, 2018 – 2023 41

FIG NO. 6. Global CHRONIC PAIN  Market Demand Volume/Revenue, By Region, 2018 – 2023 42

FIG NO. 7. Global CHRONIC PAIN  Market Supply Volume/Revenue, By Region, 2018 – 2023 43

FIG NO. 8. Global CHRONIC PAIN  Market Production Volume/Revenue, By Region, 2018 – 2023 44

FIG NO. 9. Global CHRONIC PAIN  Market Price, By Region, 2018 – 2023 45

FIG NO. 10. Global CHRONIC PAIN  Market Price, By By Indication, 2018 – 2023 46

FIG NO. 11. Raw Materials Price Trend Analysis, 2018 – 2023 47

FIG NO. 12. Manufacturing Cost Analysis 48

FIG NO. 13. Manufacturing Process 48

FIG NO. 14. Company Share Analysis, 2023 49

FIG NO. 15. Company Share Analysis, 2023 50

FIG NO. 16. Company Share Analysis, 2023 50

FIG NO. 17. Company Share Analysis, 2023 51

FIG NO. 18. CHRONIC PAIN  Market – Company Volume  Market Share, 2023 52

FIG NO. 19. CHRONIC PAIN  Market – Company Revenue Market Share, 2023 53

FIG NO. 20. CHRONIC PAIN  Market Revenue Share, By By Indication, 2023 & 2032 59

FIG NO. 21. Market Attractiveness Analysis, By By Indication 60

FIG NO. 22. Incremental Revenue Growth Opportunity by By Indication, 2024 – 2032 60

FIG NO. 23. CHRONIC PAIN  Market Revenue, By By Indication, 2018, 2023, 2027 & 2032 61

FIG NO. 24. Global CHRONIC PAIN  Market for Neuropathic Pain, Revenue (USD Million) 2018 – 2032 62

FIG NO. 25. Global CHRONIC PAIN  Market for Arthritis pain, Revenue (USD Million) 2018 – 2032 64

FIG NO. 26. Global CHRONIC PAIN  Market for Chronic Back pain , Revenue (USD Million) 2018 – 2032 66

FIG NO. 27. Global CHRONIC PAIN  Market for Cancer Pain, Revenue (USD Million) 2018 – 2032 68

FIG NO. 28. Global CHRONIC PAIN  Market for Migraine, Revenue (USD Million) 2018 – 2032 70

FIG NO. 29. CHRONIC PAIN  Market Revenue Share, By Drug Class, 2023 & 2032 73

FIG NO. 30. Market Attractiveness Analysis, By Drug Class 74

FIG NO. 31. Incremental Revenue Growth Opportunity by Drug Class, 2024 – 2032 74

FIG NO. 32. CHRONIC PAIN  Market Revenue, By Drug Class, 2018, 2023, 2027 & 2032 75

FIG NO. 33. Global CHRONIC PAIN  Market for Opiods, Revenue (USD Million) 2018 – 2032 76

FIG NO. 34. Global CHRONIC PAIN  Market for Non steroidal Anti inflamatory drugs , Revenue (USD Million) 2018 – 2032 78

FIG NO. 35. Global CHRONIC PAIN  Market for Anticonvulsants, Revenue (USD Million) 2018 – 2032 80

FIG NO. 36. Global CHRONIC PAIN  Market for Antidepressants, Revenue (USD Million) 2018 – 2032 82

FIG NO. 37. Global CHRONIC PAIN  Market for Drug Class 5, Revenue (USD Million) 2018 – 2032 84

FIG NO. 38. CHRONIC PAIN  Market Revenue Share, By Application , 2023 & 2032 87

FIG NO. 39. Market Attractiveness Analysis, By Application 88

FIG NO. 40. Incremental Revenue Growth Opportunity by Application , 2024 – 2032 88

FIG NO. 41. CHRONIC PAIN  Market Revenue, By Application , 2018, 2023, 2027 & 2032 89

FIG NO. 42. Global CHRONIC PAIN  Market for Musculoskeletal, Revenue (USD Million) 2018 – 2032 90

FIG NO. 43. Global CHRONIC PAIN  Market for Neuropathy, Revenue (USD Million) 2018 – 2032 92

FIG NO. 44. Global CHRONIC PAIN  Market for Oncology, Revenue (USD Million) 2018 – 2032 94

FIG NO. 45. Global CHRONIC PAIN  Market for Others, Revenue (USD Million) 2018 – 2032 96

FIG NO. 46. Global CHRONIC PAIN  Market for Application  5, Revenue (USD Million) 2018 – 2032 98

FIG NO. 47. CHRONIC PAIN  Market Revenue Share, By Technology, 2023 & 2032 101

FIG NO. 48. Market Attractiveness Analysis, By Technology 102

FIG NO. 49. Incremental Revenue Growth Opportunity by Technology, 2024 – 2032 102

FIG NO. 50. CHRONIC PAIN  Market Revenue, By Technology, 2018, 2023, 2027 & 2032 103

FIG NO. 51. Global CHRONIC PAIN  Market for Technology 1, Revenue (USD Million) 2018 – 2032 104

FIG NO. 52. Global CHRONIC PAIN  Market for Technology 2, Revenue (USD Million) 2018 – 2032 106

FIG NO. 53. Global CHRONIC PAIN  Market for Technology 3, Revenue (USD Million) 2018 – 2032 108

FIG NO. 54. Global CHRONIC PAIN  Market for Technology 4, Revenue (USD Million) 2018 – 2032 110

FIG NO. 55. Global CHRONIC PAIN  Market for Technology 5, Revenue (USD Million) 2018 – 2032 112

FIG NO. 56. CHRONIC PAIN  Market Revenue Share, By Distribution Channel, 2023 & 2032 115

FIG NO. 57. Market Attractiveness Analysis, By Distribution Channel 116

FIG NO. 58. Incremental Revenue Growth Opportunity by Distribution Channel, 2024 – 2032 116

FIG NO. 59. CHRONIC PAIN  Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 117

FIG NO. 60. Global CHRONIC PAIN  Market for Hospital Pharmacies, Revenue (USD Million) 2018 – 2032 118

FIG NO. 61. Global CHRONIC PAIN  Market for Retail Pharmacies, Revenue (USD Million) 2018 – 2032 120

FIG NO. 62. Global CHRONIC PAIN  Market for Others, Revenue (USD Million) 2018 – 2032 122

FIG NO. 63. Global CHRONIC PAIN  Market for  , Revenue (USD Million) 2018 – 2032 124

FIG NO. 64. Global CHRONIC PAIN  Market for Distribution Channel 5, Revenue (USD Million) 2018 – 2032 126

FIG NO. 65. Global CHRONIC PAIN  Market Revenue Share, By Region, 2023 & 2032 129

FIG NO. 66. Market Attractiveness Analysis, By Region 130

FIG NO. 67. Incremental Revenue Growth Opportunity by Region, 2024 – 2032 130

FIG NO. 68. CHRONIC PAIN  Market Revenue, By Region, 2018, 2023, 2027 & 2032 131

FIG NO. 69. North America CHRONIC PAIN  Market Revenue, 2018 – 2032 (USD Million) 138

FIG NO. 70. Europe CHRONIC PAIN  Market Revenue, 2018 – 2032 (USD Million) 146

FIG NO. 71. Asia Pacific CHRONIC PAIN  Market Revenue, 2018 – 2032 (USD Million) 154

FIG NO. 72. Latin America CHRONIC PAIN  Market Revenue, 2018 – 2032 (USD Million) 162

FIG NO. 73. Middle East CHRONIC PAIN  Market Revenue, 2018 – 2032 (USD Million) 170

FIG NO. 74. Africa CHRONIC PAIN  Market Revenue, 2018 – 2032 (USD Million) 178

FIG NO. 75. Research Methodology – Detailed View 189

FIG NO. 76. Research Methodology 190

List of Tables

TABLE NO. 1. : Global CHRONIC PAIN  Market: Snapshot 27

TABLE NO. 2. : Drivers for the CHRONIC PAIN  Market: Impact Analysis 31

TABLE NO. 3. : Restraints for the CHRONIC PAIN  Market: Impact Analysis 33

TABLE NO. 4. : Global CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 43

TABLE NO. 5. : Global CHRONIC PAIN  Market Revenue, By By Indication, 2018 – 2023 44

TABLE NO. 6. : Key Raw Materials & Suppliers 45

TABLE NO. 7. : Global Neuropathic Pain CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 61

TABLE NO. 8. : Global Neuropathic Pain CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 61

TABLE NO. 9. : Global Arthritis pain CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 63

TABLE NO. 10. : Global Arthritis pain CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 63

TABLE NO. 11. : Global Chronic Back pain  CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 65

TABLE NO. 12. : Global Chronic Back pain  CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 65

TABLE NO. 13. : Global Cancer Pain CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 67

TABLE NO. 14. : Global Cancer Pain CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 67

TABLE NO. 15. : Global Migraine CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 69

TABLE NO. 16. : Global Migraine CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 69

TABLE NO. 17. : Global Opiods CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 75

TABLE NO. 18. : Global Opiods CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 75

TABLE NO. 19. : Global Non steroidal Anti inflamatory drugs  CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 77

TABLE NO. 20. : Global Non steroidal Anti inflamatory drugs  CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 77

TABLE NO. 21. : Global Anticonvulsants CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 79

TABLE NO. 22. : Global Anticonvulsants CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 79

TABLE NO. 23. : Global Antidepressants CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 81

TABLE NO. 24. : Global Antidepressants CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 81

TABLE NO. 25. : Global Drug Class 5 CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 83

TABLE NO. 26. : Global Drug Class 5 CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 83

TABLE NO. 27. : Global Musculoskeletal CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 89

TABLE NO. 28. : Global Musculoskeletal CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 89

TABLE NO. 29. : Global Neuropathy CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 91

TABLE NO. 30. : Global Neuropathy CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 91

TABLE NO. 31. : Global Oncology CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 93

TABLE NO. 32. : Global Oncology CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 93

TABLE NO. 33. : Global Others CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 95

TABLE NO. 34. : Global Others CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 95

TABLE NO. 35. : Global Application  5 CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 97

TABLE NO. 36. : Global Application  5 CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 97

TABLE NO. 37. : Global Technology 1 CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 103

TABLE NO. 38. : Global Technology 1 CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 103

TABLE NO. 39. : Global Technology 2 CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 105

TABLE NO. 40. : Global Technology 2 CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 105

TABLE NO. 41. : Global Technology 3 CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 107

TABLE NO. 42. : Global Technology 3 CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 107

TABLE NO. 43. : Global Technology 4 CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 109

TABLE NO. 44. : Global Technology 4 CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 109

TABLE NO. 45. : Global Technology 5 CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 111

TABLE NO. 46. : Global Technology 5 CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 111

TABLE NO. 47. : Global Hospital Pharmacies CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 117

TABLE NO. 48. : Global Hospital Pharmacies CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 117

TABLE NO. 49. : Global Retail Pharmacies CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 119

TABLE NO. 50. : Global Retail Pharmacies CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 119

TABLE NO. 51. : Global Others CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 121

TABLE NO. 52. : Global Others CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 121

TABLE NO. 53. : Global   CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 123

TABLE NO. 54. : Global   CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 123

TABLE NO. 55. : Global Distribution Channel 5 CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 125

TABLE NO. 56. : Global Distribution Channel 5 CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 125

TABLE NO. 57. : Global CHRONIC PAIN  Market Revenue, By Region, 2018 – 2023 (USD Million) 130

TABLE NO. 58. : Global CHRONIC PAIN  Market Revenue, By Region, 2024 – 2032 (USD Million) 130

TABLE NO. 59. : Global CHRONIC PAIN  Market Revenue, By By Indication, 2018 – 2023 (USD Million) 131

TABLE NO. 60. : Global CHRONIC PAIN  Market Revenue, By By Indication, 2024 – 2032 (USD Million) 131

TABLE NO. 61. : Global CHRONIC PAIN  Market Revenue, By Drug Class, 2018 – 2023 (USD Million) 132

TABLE NO. 62. : Global CHRONIC PAIN  Market Revenue, By Drug Class, 2024 – 2032 (USD Million) 132

TABLE NO. 63. : Global CHRONIC PAIN  Market Revenue, By Application , 2018 – 2023 (USD Million) 133

TABLE NO. 64. : Global CHRONIC PAIN  Market Revenue, By Application , 2024 – 2032 (USD Million) 133

TABLE NO. 65. : Global CHRONIC PAIN  Market Revenue, By Technology, 2018 – 2023 (USD Million) 134

TABLE NO. 66. : Global CHRONIC PAIN  Market Revenue, By Technology, 2024 – 2032 (USD Million) 134

TABLE NO. 67. : Global CHRONIC PAIN  Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 135

TABLE NO. 68. : Global CHRONIC PAIN  Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 135

TABLE NO. 69. : North America CHRONIC PAIN  Market Revenue, By Country, 2018 – 2023 (USD Million) 137

TABLE NO. 70. : North America CHRONIC PAIN  Market Revenue, By Country, 2024 – 2032 (USD Million) 137

TABLE NO. 71. : North America CHRONIC PAIN  Market Revenue, By By Indication, 2018 – 2023 (USD Million) 138

TABLE NO. 72. : North America CHRONIC PAIN  Market Revenue, By By Indication, 2024 – 2032 (USD Million) 138

TABLE NO. 73. : North America CHRONIC PAIN  Market Revenue, By Drug Class, 2018 – 2023 (USD Million) 139

TABLE NO. 74. : North America CHRONIC PAIN  Market Revenue, By Drug Class, 2024 – 2032 (USD Million) 139

TABLE NO. 75. : North America CHRONIC PAIN  Market Revenue, By Application , 2018 – 2023 (USD Million) 140

TABLE NO. 76. : North America CHRONIC PAIN  Market Revenue, By Application , 2024 – 2032 (USD Million) 140

TABLE NO. 77. : North America CHRONIC PAIN  Market Revenue, By Technology, 2018 – 2023 (USD Million) 141

TABLE NO. 78. : North America CHRONIC PAIN  Market Revenue, By Technology, 2024 – 2032 (USD Million) 141

TABLE NO. 79. : North America CHRONIC PAIN  Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 142

TABLE NO. 80. : North America CHRONIC PAIN  Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 142

TABLE NO. 81. : Europe CHRONIC PAIN  Market Revenue, By Country, 2018 – 2023 (USD Million) 145

TABLE NO. 82. : Europe CHRONIC PAIN  Market Revenue, By Country, 2024 – 2032 (USD Million) 145

TABLE NO. 83. : Europe CHRONIC PAIN  Market Revenue, By By Indication, 2018 – 2023 (USD Million) 146

TABLE NO. 84. : Europe CHRONIC PAIN  Market Revenue, By By Indication, 2024 – 2032 (USD Million) 146

TABLE NO. 85. : Europe CHRONIC PAIN  Market Revenue, By Drug Class, 2018 – 2023 (USD Million) 147

TABLE NO. 86. : Europe CHRONIC PAIN  Market Revenue, By Drug Class, 2024 – 2032 (USD Million) 147

TABLE NO. 87. : Europe CHRONIC PAIN  Market Revenue, By Application , 2018 – 2023 (USD Million) 148

TABLE NO. 88. : Europe CHRONIC PAIN  Market Revenue, By Application , 2024 – 2032 (USD Million) 148

TABLE NO. 89. : Europe CHRONIC PAIN  Market Revenue, By Technology, 2018 – 2023 (USD Million) 149

TABLE NO. 90. : Europe CHRONIC PAIN  Market Revenue, By Technology, 2024 – 2032 (USD Million) 149

TABLE NO. 91. : Europe CHRONIC PAIN  Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 150

TABLE NO. 92. : Europe CHRONIC PAIN  Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 150

TABLE NO. 93. : Asia Pacific CHRONIC PAIN  Market Revenue, By Country, 2018 – 2023 (USD Million) 153

TABLE NO. 94. : Asia Pacific CHRONIC PAIN  Market Revenue, By Country, 2024 – 2032 (USD Million) 153

TABLE NO. 95. : Asia Pacific CHRONIC PAIN  Market Revenue, By By Indication, 2018 – 2023 (USD Million) 154

TABLE NO. 96. : Asia Pacific CHRONIC PAIN  Market Revenue, By By Indication, 2024 – 2032 (USD Million) 154

TABLE NO. 97. : Asia Pacific CHRONIC PAIN  Market Revenue, By Drug Class, 2018 – 2023 (USD Million) 155

TABLE NO. 98. : Asia Pacific CHRONIC PAIN  Market Revenue, By Drug Class, 2024 – 2032 (USD Million) 155

TABLE NO. 99. : Asia Pacific CHRONIC PAIN  Market Revenue, By Application , 2018 – 2023 (USD Million) 156

TABLE NO. 100. : Asia Pacific CHRONIC PAIN  Market Revenue, By Application , 2024 – 2032 (USD Million) 156

TABLE NO. 101. : Asia Pacific CHRONIC PAIN  Market Revenue, By Technology, 2018 – 2023 (USD Million) 157

TABLE NO. 102. : Asia Pacific CHRONIC PAIN  Market Revenue, By Technology, 2024 – 2032 (USD Million) 157

TABLE NO. 103. : Asia Pacific CHRONIC PAIN  Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 158

TABLE NO. 104. : Asia Pacific CHRONIC PAIN  Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 158

TABLE NO. 105. : Latin America CHRONIC PAIN  Market Revenue, By Country, 2018 – 2023 (USD Million) 161

TABLE NO. 106. : Latin America CHRONIC PAIN  Market Revenue, By Country, 2024 – 2032 (USD Million) 161

TABLE NO. 107. : Latin America CHRONIC PAIN  Market Revenue, By By Indication, 2018 – 2023 (USD Million) 162

TABLE NO. 108. : Latin America CHRONIC PAIN  Market Revenue, By By Indication, 2024 – 2032 (USD Million) 162

TABLE NO. 109. : Latin America CHRONIC PAIN  Market Revenue, By Drug Class, 2018 – 2023 (USD Million) 163

TABLE NO. 110. : Latin America CHRONIC PAIN  Market Revenue, By Drug Class, 2024 – 2032 (USD Million) 163

TABLE NO. 111. : Latin America CHRONIC PAIN  Market Revenue, By Application , 2018 – 2023 (USD Million) 164

TABLE NO. 112. : Latin America CHRONIC PAIN  Market Revenue, By Application , 2024 – 2032 (USD Million) 164

TABLE NO. 113. : Latin America CHRONIC PAIN  Market Revenue, By Technology, 2018 – 2023 (USD Million) 165

TABLE NO. 114. : Latin America CHRONIC PAIN  Market Revenue, By Technology, 2024 – 2032 (USD Million) 165

TABLE NO. 115. : Latin America CHRONIC PAIN  Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 166

TABLE NO. 116. : Latin America CHRONIC PAIN  Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 166

TABLE NO. 117. : Middle East CHRONIC PAIN  Market Revenue, By Country, 2018 – 2023 (USD Million) 169

TABLE NO. 118. : Middle East CHRONIC PAIN  Market Revenue, By Country, 2024 – 2032 (USD Million) 169

TABLE NO. 119. : Middle East CHRONIC PAIN  Market Revenue, By By Indication, 2018 – 2023 (USD Million) 170

TABLE NO. 120. : Middle East CHRONIC PAIN  Market Revenue, By By Indication, 2024 – 2032 (USD Million) 170

TABLE NO. 121. : Middle East CHRONIC PAIN  Market Revenue, By Drug Class, 2018 – 2023 (USD Million) 171

TABLE NO. 122. : Middle East CHRONIC PAIN  Market Revenue, By Drug Class, 2024 – 2032 (USD Million) 171

TABLE NO. 123. : Middle East CHRONIC PAIN  Market Revenue, By Application , 2018 – 2023 (USD Million) 172

TABLE NO. 124. : Middle East CHRONIC PAIN  Market Revenue, By Application , 2024 – 2032 (USD Million) 172

TABLE NO. 125. : Middle East CHRONIC PAIN  Market Revenue, By Technology, 2018 – 2023 (USD Million) 173

TABLE NO. 126. : Middle East CHRONIC PAIN  Market Revenue, By Technology, 2024 – 2032 (USD Million) 173

TABLE NO. 127. : Middle East CHRONIC PAIN  Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 174

TABLE NO. 128. : Middle East CHRONIC PAIN  Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 174

TABLE NO. 129. : Africa CHRONIC PAIN  Market Revenue, By Country, 2018 – 2023 (USD Million) 177

TABLE NO. 130. : Africa CHRONIC PAIN  Market Revenue, By Country, 2024 – 2032 (USD Million) 177

TABLE NO. 131. : Africa CHRONIC PAIN  Market Revenue, By By Indication, 2018 – 2023 (USD Million) 178

TABLE NO. 132. : Africa CHRONIC PAIN  Market Revenue, By By Indication, 2024 – 2032 (USD Million) 178

TABLE NO. 133. : Africa CHRONIC PAIN  Market Revenue, By Drug Class, 2018 – 2023 (USD Million) 179

TABLE NO. 134. : Africa CHRONIC PAIN  Market Revenue, By Drug Class, 2024 – 2032 (USD Million) 179

TABLE NO. 135. : Africa CHRONIC PAIN  Market Revenue, By Application , 2018 – 2023 (USD Million) 180

TABLE NO. 136. : Africa CHRONIC PAIN  Market Revenue, By Application , 2024 – 2032 (USD Million) 180

TABLE NO. 137. : Africa CHRONIC PAIN  Market Revenue, By Technology, 2018 – 2023 (USD Million) 181

TABLE NO. 138. : Africa CHRONIC PAIN  Market Revenue, By Technology, 2024 – 2032 (USD Million) 181

TABLE NO. 139. : Africa CHRONIC PAIN  Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 182

TABLE NO. 140. : Africa CHRONIC PAIN  Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 182

Frequently Asked Questions:

What is the projected growth of the Chronic Pain Market? 

The global chronic pain market is projected to grow from USD 78,923.16 million in 2023 to USD 84,550.38 million by 2032, at a compound annual growth rate (CAGR) of 5.37%.

What is driving the shift in the Chronic Pain Market?

The market is shifting towards personalized and integrated pain management approaches. This is due to a better understanding of chronic pain’s complex nature and the need for tailored treatment plans.

How are digital health solutions impacting the Chronic Pain Market?

Digital health solutions like telemedicine platforms and wearable devices are improving patient access to care and enhancing treatment outcomes, playing a pivotal role in the market’s growth.

What future trends are expected in the Chronic Pain Market? 

The market is expected to continue growing, driven by ongoing research, strategic collaborations, and investments in new therapies. Evolving healthcare policies and reimbursement frameworks are also expected to bolster market growth.

Chronic Smell and Flavor Loss Treatment Market

Published:
Report ID: 74348

Chronic Refractory Cough Treatment Market

Published:
Report ID: 74341

Chronic Pulmonary Hypertension Treatment Market

Published:
Report ID: 74318

Chronic Disease Management Services Market

Published:
Report ID: 74315

Chronic Brain Damage Management Market

Published:
Report ID: 67671

Chronic Hepatitis B Virus Testing Market

Published:
Report ID: 66263

Brazil Chronic Pain Market

Published:
Report ID: 65824

Canada Chronic Pain Market

Published:
Report ID: 65303

Switzerland Chronic Pain Market

Published:
Report ID: 65157

Congenital Adrenal Hyperplasia Treatment Market

Published:
Report ID: 75587

Memory Support Supplement Market

Published:
Report ID: 75433

Melatonin Sleep Supplements Market

Published:
Report ID: 75427

L-Lysine Hydrochloride HCL Market

Published:
Report ID: 75417

Immune Health Supplements Market

Published:
Report ID: 75385

Clinical Decision Support Market

Published:
Report ID: 75353

Lights for Dental Healthcare Market

Published:
Report ID: 75196

AIDS Related Primary CNS Lymphoma Market

Published:
Report ID: 75163

Acid Citrate Dextrose Tubes Market

Published:
Report ID: 75120

Intestinal Fistula Treatment Market

Published:
Report ID: 75108

Hypersensitivity Pneumonitis Market

Published:
Report ID: 75098

Incontinence Care Products Market

Published:
Report ID: 75078

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$4699

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$5699

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
$7699

Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN